Bristol-Myers Buy Medarex For $2.4B
Bloomberg
Jul. 23, 2009. 05:09 AM EST
Bristol-Myers buys Medarex for $2.4 billion to gain ownership of a skin cancer drug that is neari... More »
Bristol-Myers buys Medarex for $2.4 billion to gain ownership of a skin cancer drug that is nearing F.D.A approval. (Bloomberg News) « Less
-
NYSE Opening Bell Market Monitor: DIS, DELL, NYT
New York Financial Press
Feb. 10, 2010. 10:43 AM EST
-
AP Top Stories
Associated Press
Feb. 10, 2010. 07:47 AM EST
-
U.S. Job Openings and Hirings Face Challenges
New York Financial Press
Feb. 10, 2010. 04:00 AM EST
-
Honda Adds 400,000 Cars to Recall List
Associated Press
Feb. 10, 2010. 03:16 AM EST
-
Toyota Tries to Control Damage
Associated Press
Feb. 10, 2010. 12:09 AM EST
-
Newark Airport Suspect Pleads Not Guilty
Associated Press
Feb. 10, 2010. 12:08 AM EST
-
The Day Ahead: U.S. Trade Balance
New York Financial Press
Feb. 09, 2010. 10:00 PM EST
-
Want Big Savings? Just Ask!
Money Talks
Feb. 09, 2010. 05:55 PM EST
-
McDonald's January Profit Surges On International Sales
New York Financial Press
Feb. 09, 2010. 04:59 PM EST
-
NYSE Closing Bell Market Monitor: CAT, KO, MCD
New York Financial Press
Feb. 09, 2010. 04:43 PM EST


